If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,454.00    32.00 (2.25%)
Bid:
1,442.00
Ask:
1,456.00
Spread: 14.00 (0.971%)
Market Cap: £666.37m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

Director/PDMR Shareholding

14 Aug 2014 09:30

RNS Number : 1263P
Cohort PLC
14 August 2014
 



14 August 2014

COHORT PLC (the "Company")

Director Shareholdings, Share Awards and Options

Cohort plc (the "Company") wishes to notify the following changes in the interests of directors of the Company in ordinary shares of 10 pence in relation to share awards and share options.

Director shareholdings

Yesterday, the Company was notified that the sale of shares to satisfy share option exercise costs took place on 12 August 2014 as follows:

Description

Ordinary Shares

Market Value(pence)

Sale by AS Thomis' wife

25,477

197.25 p

Sale by SR Walther

7,644

197.25 p

Sale by SR Walther's wife

7,643

197.25 p

Following all transactions to date, including those detailed below, and subject to the completion of ISA transfers announced on 5 August 2014, Mr Thomis' and Mr Walther's interests and that of their connected persons are as follows:

Director

Ordinary shares

% of the total issued share capital

AS Thomis

86,225

0.21

SR Walther

78,892

0.19

Grant of Share Awards

On 11 August 2014 share awards pursuant to the 2013 Restricted Share Scheme established on 30 July 2013 ("Restricted Share Scheme") were granted to directors of the Company for nil consideration as follows:

Director

Number of sharesunder this award

Total number of unvested shares under the Restricted Share Scheme following grant

AS Thomis

19,342

20,556

SR Walther

15,595

17,196

Full beneficial ownership of Restricted Shares (including voting and dividend rights) will transfer to the recipients in stages over a three-year period from the date of grant. Recipients may only sell Restricted Shares with the approval of the Chairman of the Remuneration & Appointments Committee while they remain in employment with the Company. Further details regarding the Restricted Shares can be found in the Company's Annual Report and Accounts 2014.

Grant of Share Options

On 11 August 2014 share options pursuant to the Cohort plc 2006 Share Option Scheme ("Unapproved") and the Approved Share Option Subplan ("Approved") were granted to directors of the Company as follows:

Director

Number of shares under this option

Exercise Price(pence)

Total number of shares under option following grant

AS Thomis - Unapproved

4,153

197.5

246,944

Approved

15,189

197.5

15,189

SR Walther - Unapproved

406

197.5

172,580

Approved

15,189

197.5

15,189

The options can be exercised between 12 August 2017 and 11 August 2024.

On 11 August 2014 share options pursuant to the Cohort plc Savings Related Share Option Scheme ("SAYE Scheme") were granted to directors of the Company as follows:

Director

Number of shares underthis option

Exercise Price (pence)

Total number of shares under the SAYE Scheme following grant

AS Thomis

2,602

207.5

4,932

SR Walther

867

207.5

6,692

The options are made pursuant to three year savings contracts.

The total share options held under each scheme following grant as set out above includes the recent exercise of share options announced on 5 August 2014.

Ends

For further information, please contact

Cohort plc

Andrew Thomis, Chief ExecutiveSimon Walther, Finance Director

+44 (0)118 909 0390

Investec

Keith Anderson, Daniel Adams

+44 (0)20 7597 5970

MHP Communications

Reg Hoare, Vicky Watkins

+44 (0)20 3128 8100

Cohort plc

Cohort is an independent technology group working primarily for defence (air, land and sea), wider government and industry clients, through four market-facing subsidiary companies:

MASS - a specialist systems house with considerable experience in the defence market and a focus on electronic warfare operational support and secure information systems. Based in Cambridgeshire, MASS was acquired by Cohort in August 2006;

MCL - an expert in electronic and surveillance technology design and manufacturing, product and in the field support and training for a range of specialist UK end users, including the MOD and other governmental agencies. Based in Surrey, MCL has been part of the Group since July 2014;

SCS - a defence technical advisory business, combining technical expertise with practical experience and domain knowledge. Owned by Cohort since flotation in March 2006;

SEA - an advanced surveillance systems and software house with hardware development capability operating in the defence and transport market sectors. Acquired by Cohort in October 2007.

Cohort was admitted to London's Alternative Investment Market in March 2006. It has its headquarters in Berkshire and employs in total around 500 core staff there and at its other operating company sites in Bristol, Cambridgeshire, Lincolnshire, Somerset and Surrey.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSGIGDIGXBBGSS
Date   Source Headline
6th Aug 202111:51 amRNSDirector/PDMR Shareholding
6th Aug 20217:00 amRNSMCL wins contracts with MoD
5th Aug 20211:42 pmRNSDirector/PDMR Shareholding
5th Aug 20219:41 amRNSDirector/PDMR Shareholding
27th Jul 20217:00 amRNSAppointment of Non-Executive Director
27th Jul 20217:00 amRNSPreliminary Results
14th Jul 202111:58 amRNSNotice of Results
7th Jul 20217:00 amRNSELAC SONAR wins EUR49m contract for Italian Navy
10th Jun 20213:35 pmRNSHolding(s) in Company
1st Jun 20214:41 pmRNSSecond Price Monitoring Extn
1st Jun 20214:35 pmRNSPrice Monitoring Extension
26th May 20217:00 amRNSTrading Update
25th May 20214:40 pmRNSSecond Price Monitoring Extn
25th May 20214:35 pmRNSPrice Monitoring Extension
30th Apr 20212:01 pmRNSTotal Voting Rights
6th Apr 20212:10 pmRNSDirector/PDMR Shareholding
1st Apr 202110:28 amRNSTotal Voting Rights
1st Apr 202110:27 amRNSBlock listing Interim Review
31st Mar 20214:45 pmRNSHolding(s) in Company
29th Mar 20212:40 pmRNSSEA wins £25m contract with UK MoD
11th Mar 20217:00 amRNSContract Wins
3rd Mar 20212:05 pmRNSResponse to Press Speculation
26th Feb 20212:30 pmRNSTotal Voting Rights
24th Feb 20214:42 pmRNSBlock listing Interim Review
11th Feb 20215:41 pmRNSDirector/PDMR Shareholding
9th Feb 20219:30 amRNSEBT Purchase of Shares
8th Feb 20215:31 pmRNSDirector/PDMR Shareholding
29th Jan 202110:31 amRNSTotal Voting Rights
12th Jan 20216:10 pmRNSDirector/PDMR Shareholding
5th Jan 20217:00 amRNSInterim Report
31st Dec 20209:22 amRNSTotal Voting Rights
14th Dec 20201:51 pmRNSEBT Purchase of Shares
11th Dec 20202:12 pmRNSDirector/PDMR Shareholding
10th Dec 20205:35 pmRNSDirector/PDMR Shareholding
10th Dec 20207:00 amRNSHalf Year Results
3rd Dec 20207:00 amRNSCompletion of Acquisition
30th Nov 202011:21 amRNSTotal Voting Rights
19th Nov 20207:00 amRNSNotice of Interim Results Date
4th Nov 20201:24 pmRNSTotal Voting Rights
30th Oct 20204:59 pmRNSTotal Voting Rights
26th Oct 20206:13 pmRNSHolding(s) in Company
21st Oct 20207:00 amRNSContract Wins
14th Oct 20202:53 pmRNSDirector/PDMR Shareholding
5th Oct 20205:58 pmRNSEBT purchase and exercise of Share Options
28th Sep 20202:36 pmRNSBlock Listing Application
25th Sep 20205:10 pmRNSDirector/PDMR Shareholding
21st Sep 20202:05 pmRNSEBT Purchase and Director Shareholdings
15th Sep 20203:39 pmRNSResult of AGM
15th Sep 20201:13 pmRNSDirector/PDMR Shareholding
15th Sep 20207:00 amRNSAGM Statement & First Quarter Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.